Andre van As

2.6k total citations · 1 hit paper
22 papers, 2.0k citations indexed

About

Andre van As is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Andre van As has authored 22 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 14 papers in Pulmonary and Respiratory Medicine and 8 papers in Immunology and Allergy. Recurrent topics in Andre van As's work include Asthma and respiratory diseases (17 papers), Respiratory and Cough-Related Research (8 papers) and Allergic Rhinitis and Sensitization (7 papers). Andre van As is often cited by papers focused on Asthma and respiratory diseases (17 papers), Respiratory and Cough-Related Research (8 papers) and Allergic Rhinitis and Sensitization (7 papers). Andre van As collaborates with scholars based in United States, United Kingdom and Australia. Andre van As's co-authors include William W. Busse, Giovanni Della Cioppa, Angel FowlerTaylor, Jonathan Corren, Niroo Gupta, Bobby Q. Lanier, Robert J. Dockhorn, Paul Chervinsky, James P. Kemp and Jay Grossman and has published in prestigious journals such as New England Journal of Medicine, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Andre van As

22 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

2001 978 citations William W. Busse, Jonathan Corren et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andre van As United States	15	1.7k	1.3k	678	223	114	22	2.0k
Orion P. Twentyman United Kingdom	14	1.5k 0.9×	1.3k 1.1×	392 0.6×	281 1.3×	8 0.1×	20	2.1k
Manlio Milanese Italy	23	1.2k 0.7×	843 0.7×	544 0.8×	115 0.5×	11 0.1×	72	1.4k
Russell J. Hopp United States	21	1.3k 0.7×	856 0.7×	419 0.6×	269 1.2×	5 0.0×	98	1.8k
V. GRAFF‐LONNEVIG Sweden	18	700 0.4×	260 0.2×	687 1.0×	47 0.2×	3 0.0×	33	1.1k
Hiroyuki Mochizuki Japan	21	802 0.5×	992 0.8×	111 0.2×	94 0.4×	3 0.0×	132	1.5k
Joanne Clough United Kingdom	22	963 0.6×	654 0.5×	258 0.4×	313 1.4×	2 0.0×	44	1.4k
William B. Klaustermeyer United States	16	341 0.2×	233 0.2×	251 0.4×	147 0.7×	7 0.1×	72	929
Andrzej Bożek Poland	21	792 0.5×	289 0.2×	693 1.0×	132 0.6×	14 0.1×	106	1.2k
D.P. Dhillon United Kingdom	16	450 0.3×	593 0.5×	42 0.1×	39 0.2×	5 0.0×	29	911
Anna Bręborowicz Poland	17	418 0.2×	302 0.2×	247 0.4×	189 0.8×	2 0.0×	104	1.0k

Countries citing papers authored by Andre van As

Since Specialization

Citations

This map shows the geographic impact of Andre van As's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andre van As with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andre van As more than expected).

Fields of papers citing papers by Andre van As

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andre van As. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andre van As. The network helps show where Andre van As may publish in the future.

Co-authorship network of co-authors of Andre van As

This figure shows the co-authorship network connecting the top 25 collaborators of Andre van As. A scholar is included among the top collaborators of Andre van As based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andre van As. Andre van As is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Adler, Kenneth B., Monica Kraft, Indu Parikh, Edward Murphy, & Andre van As. (2011). Results of a phase 2a clinical trial with a peptide inhibitor of MARCKS protein indicate improvement of indices of bronchitis and lung function in patients with COPD. European Respiratory Journal. 38(Suppl 55). 4901–4901. 2 indexed citations

Wiehle, Ronald D., et al.. (2008). ANDROXAL™ (ENCLOMIPHENE CITRATE) ACTS CENTRALLY ON THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS TO INCREASE LH, FSH AND TESTOSTERONE IN MEN WITH ADULT IDIOPATHIC HYPOGONADOTROPHIC HYPOGONADISM. The Journal of Urology. 179(4S). 426–426. 2 indexed citations

Чучалин, А. Г., Kai Richter, Norbert Krug, et al.. (2007). Safety and tolerability of indacaterol in asthma: A randomized, placebo-controlled 28-day study. Respiratory Medicine. 101(10). 2065–2075. 36 indexed citations

Derom, Eric, et al.. (2007). Indacaterol, a novel inhaled β₂-agonist, provides sustained 24-h bronchodilation in asthma. European Respiratory Journal. 29(5). 871–878. 49 indexed citations

Wolfe, James, Craig LaForce, Bruce Friedman, et al.. (2006). Formoterol, 24 μg bid, and Serious Asthma Exacerbations. CHEST Journal. 129(1). 27–38. 29 indexed citations

Busse, William W., Jonathan Corren, Bobby Q. Lanier, et al.. (2001). Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. Journal of Allergy and Clinical Immunology. 108(2). 184–190. 978 indexed citations breakdown →

Schwartz, Howard J., Malcolm N. Blumenthal, Sheldon R. Braun, et al.. (1996). A Comparative Study of the Clinical Efficacy of Nedocromil Sodium and Placebo. CHEST Journal. 109(4). 945–952. 22 indexed citations

Munk, Zev M., David S. Pearlman, David F. Graft, et al.. (1994). Intranasal Fluticasone Propionate Is Effective and Well-Tolerated in Adolescents with Seasonal Allergic Rhinitis. Pediatric Asthma Allergy & Immunology. 8(1). 39–46. 13 indexed citations

Kemp, James P., Robert J. Dockhorn, William W. Busse, Eugene R. Bleecker, & Andre van As. (1994). Prolonged Effect of Inhaled Salmeterol against Exercise-Induced Bronchospasm. American Journal of Respiratory and Critical Care Medicine. 150(6). 1612–1615. 67 indexed citations

10.

Bronsky, Edwin A., James P. Kemp, H.Alice Orgel, et al.. (1994). A 1-Week Dose-Ranging Study of Inhaled Salmeterol in Patients With Asthma. CHEST Journal. 105(4). 1032–1037. 16 indexed citations

11.

Chervinsky, Paul, Andre van As, Edwin A. Bronsky, et al.. (1994). Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. Journal of Allergy and Clinical Immunology. 94(4). 676–683. 137 indexed citations

12.

As, Andre van, Edwin A. Bronsky, Robert J. Dockhorn, et al.. (1993). Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate. Journal of Allergy and Clinical Immunology. 91(6). 1146–1154. 64 indexed citations

13.

Dockhorn, Robert J., Barry R. Paull, Eli O. Meltzer, et al.. (1993). Once- versus Twice-Daily Fluticasone Propionate Aqueous Nasal Spray for Seasonal Allergic Rhinitis. American Journal of Rhinology. 7(2). 77–83. 10 indexed citations

14.

Pearlman, David S., Paul Chervinsky, Craig LaForce, et al.. (1992). A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate Asthma. New England Journal of Medicine. 327(20). 1420–1425. 290 indexed citations

15.

As, Andre van, et al.. (1991). Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis.. PubMed. 67(2 Pt 1). 156–62. 48 indexed citations

16.

Tinkelman, David G., James P. Kemp, Jerald W. Koepke, et al.. (1990). Evaluation of the Safety and Efficacy of Multiple Doses of Azelastine to Adult Patients with Bronchial Asthma over Time. American Review of Respiratory Disease. 141(3). 569–574. 19 indexed citations

17.

Mackinnon, L. T., Thomas W. Chick, Andre van As, & Thomas B. Tomasi. (1989). Decreased secretory immunoglobulins following intense endurance exercise. Sports medicine, training, and rehabilitation. 1(3). 209–218. 41 indexed citations

18.

Mackinnon, L. T., Thomas W. Chick, Andre van As, & T. B. Tomasi. (1987). The Effect of Exercise on Secretory and Natural Immunity. Advances in experimental medicine and biology. 216A. 869–876. 87 indexed citations

19.

Bronsky, Edwin A., Paul Chervinsky, John J. Condemi, et al.. (1987). Comparison of inhaled albuterol powder and aerosol in asthma. Journal of Allergy and Clinical Immunology. 79(5). 741–747. 35 indexed citations

20.

Chick, Thomas W., et al.. (1986). The Effect of Nifedipine on Cardiopulmonary Responses during Exercise in Normal Subjects. CHEST Journal. 89(5). 641–646. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact